NASDAQ | ETF
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions.
The fund generally is expected to consist of more than 15 companies but not more than 100 companies.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 7.09% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 5.79% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 5.01% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 4.26% |
| 0QIU | Novo Nordisk A/S Class B | 3.99% | ||
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 3.94% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 3.93% |
| 4519 | Chugai Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - General | 3.90% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 3.78% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.72% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.63% |
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 3.21% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 2.84% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.63% |
| MREO | Mereo BioPharma Group PLC ADR | Healthcare | Biotechnology | 2.61% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.59% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 2.54% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 2.36% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.27% |
| MLYS | Mineralys Therapeutics, Inc. Common Stock | Healthcare | Biotechnology | 2.03% |